ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting

WILMINGTON, DE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced it will showcase the latest technologies from its Global Foot and Ankle business at the American College of Foot & Ankle (ACFAS) annual meeting in Tampa, Fla., from February 1-4, 2024. The company will feature products from its recent acquisitions of Novastep® and the external fixation assets of D.N.E., LLC, along with the internally developed Evolve34™ Lapidus Correction System, and the STAR+ Experience with Patient Specific Instrumentation.

“With a commitment to advancing technology and improving user experience, we are proud to share our newest technologies at this year’s meeting,” stated Gary Justak, President and General Manager of Enovis™ Foot and Ankle. “Our recent acquisition of Novastep® and the Pecaplasty® Percutaneous Bunion Correction System will drive outcome improvements with an underserved patient population, and the MIS bunion surgery provides efficiency in the OR for the surgeon, while improving patient recovery times with less pain.1,2,3”

Being showcased at ACFAS for the first time will be Evolve34™, a bunion solution for Lapidus correction that allows surgeons to dial in deformity correction and select a hardware construct specific for the patient’s needs. Additionally, Enovis will be introducing the all new EF1 External Fixation product line, complimenting the flagship DynaNail® and DynaClip™ offerings in the hindfoot segment.

Enovis will also highlight products from its foot and ankle continuum of care, including the following products from its subsidiary DJO, LLC:

In addition, visitors can request samples of two new, upcoming Enovis Foot & Ankle products:

  • Arsenal Foot Plating – Booth visitors can see recent updates including technologies from the company’s Arsenal Ankle Plating System such as Type II Anodization and lower profile plating.
  • Tiger Cannulated Screw System - The revamped Tiger Cannulated Screw System includes an updated hexalobe head and size variations that booth visitors can ask to see.

ACFAS attendees have opportunities throughout the week to experience these product offerings firsthand at Booth #601, along with the following events:

  • Enovis Lab at ACFAS – “Transforming Lapidus Correction Surgery: Modern Techniques & Innovations.” Experience the powerful correction, predictable results, and procedural flexibility of Evolve34™ Lapidus Correction System during this sawbones lab on Thursday, February 1 from 1:30-2:30 p.m. This is part of the ACFAS Innovation Lab right on the Exhibit Floor at the back of the 1100 aisle. Register here: https://web.cvent.com/event/344decd8-b2a4-4183-990f-44e040a277a4/summary
  • Enovis Customer Event – “The Foot & Ankle Experience.” Join us at the Tampa Aquarium Rooftop Terrace on Friday, February 2 from 5:30 p.m. - 8:00 p.m. and take a deep dive into Enovis' latest offerings from percutaneous bunion solutions to Lapidus specific solutions, external fixation and more. Register here: https://web.cvent.com/event/220f21a0-608a-4b07-a19c-aed87a863ec2/summary



About Enovis

Enovis Corporation (NYSE: ENOV) is an innovation-driven, medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit www.enovis.com.


  1. Lee M, Walsh J, Smith MM, Ling J, Wines A, Lam P. Hallux valgus correction comparing percutaneous chevron/Akin (PECA) and open scarf/Akin osteotomies. Foot Ankle Int. 2017;38(8):838-846. doi:10.1177/1071100717704941
  2. Maffulli N, Longo UG, Oliva F, Denaro V, Coppola C. Bosch osteotomy and scarf osteotomy for hallux valgus correction. Orthop Clin North Am. 2009;40(4):515-524. doi:10.1016/j.ocl.2009.06.003
  3. Lam P, Lee M, Xing J, Di Nallo M. Percutaneous surgery for mild to moderate hallux valgus. Foot Ankle Clin. 2016;21(3):459-477. doi:10.1016/j.fcl.2016.04.001



Media Contact:
Megan Foltz Nayak
609-680-0996
Megan.Foltz@enovis.com

Attachment


Media Contact:
Megan Foltz Nayak
609-680-0996
Megan.Foltz@enovis.com

Primary Logo

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.